Codexis, Inc. (CDXS) vs Nkarta, Inc. (NKTX)
- Codexis, Inc. CDXS 1.24 −8.82%
- Nkarta, Inc. NKTX 1.82 −5.70%
Codexis, Inc. and Nkarta, Inc. are both Biotechnology companies. Codexis, Inc. and Nkarta, Inc. are of similar size ($148.9M and $138.2M). Nkarta, Inc. has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (−127.2% vs −151.2%). Across the 14 metrics below, Nkarta, Inc. leads on 8 and Codexis, Inc. on 6.
Valuation
Profitability
| Metric | CDXS | NKTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.02% | 0.00% | 65.16% |
| Operating margin | (35.61%) | 0.00% | 0.00% |
| Net margin | (39.55%) | 0.00% | 0.00% |
| Free cash flow margin | (15.66%) | 0.00% | 0.00% |
| Return on equity | (69.36%) | (38.76%) | (56.36%) |
| Return on assets | (23.79%) | (29.86%) | (48.04%) |
| Return on invested capital | (151.17%) | (127.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack